TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pensa Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/03 | 2023/03 | 2021/12 |
| Turnover |
15,393
|
32,130
|
38,271 |
| Financial expenses |
18
|
101
|
1 |
| Earnings before taxes |
-1,716
|
-3,722
|
1,049 |
| EBITDA |
1,408
|
-3,345
|
982 |
| Total assets |
17,235
|
28,735
|
28,397 |
| Current assets |
17,209
|
22,612
|
17,286 |
| Current liabilities |
3,317
|
10,318
|
6,818 |
| Equity capital |
13,918
|
18,417
|
21,579 |
| - share capital |
1,015
|
1,005
|
975 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Solvency |
80.8%
|
64.1%
|
76.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-11.1%
|
-11.6%
|
2.7% |
| Return on assets (ROA) |
-9.9%
|
-12.6%
|
3.7% |
| Current ratio |
518.8%
|
219.2%
|
253.5% |
| Return on equity (ROE) |
-12.3%
|
-20.2%
|
4.9% |
| Change turnover |
-17,073
|
-7,293
|
16,389 |
| Change turnover % |
-53%
|
-19%
|
75% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.